Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 6Withdrawn 2Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 9Other hematologic neoplasm 8Plasma cell 6Gastrointestinal 6Myeloid 5CNS 5Genitourinary 4Breast 4Dermatologic 3Thoracic 2Sarcoma 2Endocrine 2Other solid neoplasm 1NET 1Classical hematology 1

Conditions

Small Cell Lung Carcinoma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 158Pemetrexed 135Cisplatin 115pembrolizumab 99Docetaxel 94Paclitaxel 89Gemcitabine 63Erlotinib Hydrochloride 60Radiotherapy 55Nivolumab 55Bevacizumab 46Etoposide 42atezolizumab 33Radiosurgery 33durvalumab 28Cyclophosphamide 22Vinorelbine 21Ipilimumab 21Radiation 20Taxes 17130-nm albumin-bound paclitaxel 17Albumin-Bound Paclitaxel 16Gefitinib 14Irinotecan 13Drug Therapy 13osimertinib 12avelumab 12Magnetic Resonance Spectroscopy 12Dexamethasone 12Cetuximab 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Panobinostat × Thoracic × Clear all
NCT00958022 2017-06-22

Carboplatin and Etoposide Plus LBH589 for Small Cell Lung Cancer

University of Pittsburgh

Phase 1 Terminated
7 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT00907179 2015-07-22

Pemetrexed and LBH589 in Patients With Advanced Non-Small Cell Lung Cancer

University of Pittsburgh

Phase 1 Terminated
12 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡